Search for: "Fresenius USA" Results 1 - 20 of 92
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 May 2023, 5:35 am by Moll Law Group
On March 10th of this year, Fresenius Kabi USA put out an Urgent Medical Device Recall letter to their customers, typically medical providers, to let them know about the defect and to advise them to maintain a secondary large volume pump on hand in case a system failure occurred to stop disruption of vital fluids, blood, and medications. [read post]
11 Apr 2023, 2:44 pm by Lawrence B. Ebert
Fresenius Kabi USA, LLC, 946 F.3d 1322, 1332 (Fed. [read post]
4 Aug 2022, 7:53 pm by Hyman Phelps McNamara
Ryan Daniel, Chief Patent Counsel from Fresenius Kabi USA, and 2022 Co-Chair says, “We’re excited to participate in ACI’s 8th Annual Paragraph IV Master Symposium, here in Chicago and in person for the first time in three years. [read post]
27 May 2020, 2:02 pm by Eileen McDermott
On April 23, the Court requested a response from ALE USA, Inc., which had waived its right to respond earlier that month. [read post]
17 Apr 2020, 4:15 am by Eileen McDermott
ALE USA, Inc. asking the Court to weigh in on when a patent judgment becomes final.... [read post]
16 Apr 2020, 9:45 am by Dennis Crouch
The court’s approach was originally solidified in Fresenius USA, Inc. v. [read post]
10 Jan 2020, 9:15 am by Nancy Braman
Hospira sued Fresenius Kabi USA LLC (Fresenius) for infringement of... [read post]
10 Jan 2020, 9:15 am by Nancy Braman
Hospira sued Fresenius Kabi USA LLC (Fresenius) for infringement of claim 6 of the ‘106 patent, over its filing of an Abbreviated New Drug Application (ANDA) regarding its ready-to-use generic dexmedetomidine product. [read post]
23 May 2019, 1:34 pm by Overhauser Law Offices, LLC
Judges in the Indiana Court of Appeals issued their Opinion in the case of Neptune Generics, LLC, and Fresenius Kabi USA, LLC (collectively “Petitioners”) versus Eli Lilly and Company. [read post]